Concepedia

Christopher A. Chamberlain

CA

13

Publications

418

Citations

11

H-Index

2018

Active since

Affiliations

Copenhagen University Hospital(Current)

University of Copenhagen

Gentofte Hospital

Danish Cancer Society

Eötvös Loránd University

Christopher A. Chamberlain is an author at Copenhagen University Hospital specializing in tumor biology, tumor immunology, and immunology.

ORCID

Top concepts

Publications per year

2018–2023

13

Publications

13

T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

Rikke Andersen, Troels Holz Borch, Arianna Draghi et al. · Annals of Oncology · 2018 · 75 citations · Full text

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

Christopher A. Chamberlain, Eric Bennett, Anders Kverneland et al. · Molecular Therapy — Oncolytics · 2022 · 64 citations · Full text

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

Anders Kverneland, Christopher A. Chamberlain, Troels Holz Borch et al. · Journal for ImmunoTherapy of Cancer · 2021 · 61 citations · Full text

Differential effects of corticosteroids and anti‐TNF on tumor‐specific immune responses: implications for the management of irAEs

Arianna Draghi, Troels Holz Borch, Haja Dominike Radic et al. · International Journal of Cancer · 2018 · 47 citations · Full text

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

Inna M. Chen, Marco Donia, Christopher A. Chamberlain et al. · European Journal of Cancer · 2022 · 30 citations · Full text

Rows per page

1–5 of 13